Literature DB >> 26538314

Lessons from Hot Spot Analysis for Fragment-Based Drug Discovery.

David R Hall1, Dima Kozakov2, Adrian Whitty3, Sandor Vajda4.   

Abstract

Analysis of binding energy hot spots at protein surfaces can provide crucial insights into the prospects for successful application of fragment-based drug discovery (FBDD), and whether a fragment hit can be advanced into a high-affinity, drug-like ligand. The key factor is the strength of the top ranking hot spot, and how well a given fragment complements it. We show that published data are sufficient to provide a sophisticated and quantitative understanding of how hot spots derive from a protein 3D structure, and how their strength, number, and spatial arrangement govern the potential for a surface site to bind to fragment-sized and larger ligands. This improved understanding provides important guidance for the effective application of FBDD in drug discovery.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26538314      PMCID: PMC4640985          DOI: 10.1016/j.tips.2015.08.003

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  88 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

Review 2.  Structure-based druggability assessment--identifying suitable targets for small molecule therapeutics.

Authors:  Eric B Fauman; Brajesh K Rai; Enoch S Huang
Journal:  Curr Opin Chem Biol       Date:  2011-06-23       Impact factor: 8.822

3.  Experiences in fragment-based lead discovery.

Authors:  Roderick E Hubbard; James B Murray
Journal:  Methods Enzymol       Date:  2011       Impact factor: 1.600

4.  Identification of novel inhibitors of urokinase via NMR-based screening.

Authors:  P J Hajduk; S Boyd; D Nettesheim; V Nienaber; J Severin; R Smith; D Davidson; T Rockway; S W Fesik
Journal:  J Med Chem       Date:  2000-10-19       Impact factor: 7.446

5.  Application of fragment screening by X-ray crystallography to beta-secretase.

Authors:  Christopher W Murray; Owen Callaghan; Gianni Chessari; Anne Cleasby; Miles Congreve; Martyn Frederickson; Michael J Hartshorn; Rachel McMenamin; Sahil Patel; Nicola Wallis
Journal:  J Med Chem       Date:  2007-02-22       Impact factor: 7.446

6.  Development of 2-aminooxazoline 3-azaxanthenes as orally efficacious β-secretase inhibitors for the potential treatment of Alzheimer's disease.

Authors:  Jian Jeffrey Chen; Qingyian Liu; Chester Yuan; Vijay Gore; Patricia Lopez; Vu Ma; Albert Amegadzie; Wenyuan Qian; Ted C Judd; Ana E Minatti; James Brown; Yuan Cheng; May Xue; Wenge Zhong; Thomas A Dineen; Oleg Epstein; Jason Human; Charles Kreiman; Isaac Marx; Matthew M Weiss; Stephen A Hitchcock; Timothy S Powers; Kui Chen; Paul H Wen; Douglas A Whittington; Alan C Cheng; Michael D Bartberger; Dean Hickman; Jonathan A Werner; Hugo M Vargas; Nancy E Everds; Steven L Vonderfecht; Robert T Dunn; Stephen Wood; Robert T Fremeau; Ryan D White; Vinod F Patel
Journal:  Bioorg Med Chem Lett       Date:  2015-01-08       Impact factor: 2.823

7.  Fragment-based discovery of mexiletine derivatives as orally bioavailable inhibitors of urokinase-type plasminogen activator.

Authors:  Martyn Frederickson; Owen Callaghan; Gianni Chessari; Miles Congreve; Suzanna R Cowan; Julia E Matthews; Rachel McMenamin; Donna-Michelle Smith; Mladen Vinković; Nicola G Wallis
Journal:  J Med Chem       Date:  2007-12-29       Impact factor: 7.446

8.  New Frontiers in Druggability.

Authors:  Dima Kozakov; David R Hall; Raeanne L Napoleon; Christine Yueh; Adrian Whitty; Sandor Vajda
Journal:  J Med Chem       Date:  2015-08-11       Impact factor: 7.446

9.  Requirements for specific binding of low affinity inhibitor fragments to the SH2 domain of (pp60)Src are identical to those for high affinity binding of full length inhibitors.

Authors:  Gudrun Lange; Dominique Lesuisse; Pierre Deprez; Bernard Schoot; Petra Loenze; Didier Bénard; Jean-Pierre Marquette; Pierre Broto; Edoardo Sarubbi; Eliane Mandine
Journal:  J Med Chem       Date:  2003-11-20       Impact factor: 7.446

10.  Probing hot spots at protein-ligand binding sites: a fragment-based approach using biophysical methods.

Authors:  Alessio Ciulli; Glyn Williams; Alison G Smith; Tom L Blundell; Chris Abell
Journal:  J Med Chem       Date:  2006-08-10       Impact factor: 7.446

View more
  22 in total

1.  The Ligand Binding Landscape of Diacylglycerol Kinases.

Authors:  Caroline E Franks; Sean T Campbell; Benjamin W Purow; Thurl E Harris; Ku-Lung Hsu
Journal:  Cell Chem Biol       Date:  2017-07-14       Impact factor: 8.116

2.  Interaction Energetics and Druggability of the Protein-Protein Interaction between Kelch-like ECH-Associated Protein 1 (KEAP1) and Nuclear Factor Erythroid 2 Like 2 (Nrf2).

Authors:  Mengqi Zhong; Andrew Lynch; Samantha N Muellers; Stefan Jehle; Lingqi Luo; David R Hall; Reina Iwase; James P Carolan; Megan Egbert; Amanda Wakefield; Kristina Streu; Christine M Harvey; Paula C Ortet; Dima Kozakov; Sandor Vajda; Karen N Allen; Adrian Whitty
Journal:  Biochemistry       Date:  2020-01-02       Impact factor: 3.162

3.  Why Some Targets Benefit from beyond Rule of Five Drugs.

Authors:  Megan Egbert; Adrian Whitty; György M Keserű; Sandor Vajda
Journal:  J Med Chem       Date:  2019-06-26       Impact factor: 7.446

4.  Exploring the structural origins of cryptic sites on proteins.

Authors:  Dmitri Beglov; David R Hall; Amanda E Wakefield; Lingqi Luo; Karen N Allen; Dima Kozakov; Adrian Whitty; Sandor Vajda
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-26       Impact factor: 11.205

5.  Structure-Based Analysis of Cryptic-Site Opening.

Authors:  Zhuyezi Sun; Amanda Elizabeth Wakefield; Istvan Kolossvary; Dmitri Beglov; Sandor Vajda
Journal:  Structure       Date:  2019-12-03       Impact factor: 5.006

6.  Methods for Discovering and Targeting Druggable Protein-Protein Interfaces and Their Application to Repurposing.

Authors:  E Sila Ozdemir; Farideh Halakou; Ruth Nussinov; Attila Gursoy; Ozlem Keskin
Journal:  Methods Mol Biol       Date:  2019

Review 7.  Kinase Atlas: Druggability Analysis of Potential Allosteric Sites in Kinases.

Authors:  Christine Yueh; Justin Rettenmaier; Bing Xia; David R Hall; Andrey Alekseenko; Kathryn A Porter; Krister Barkovich; Gyorgy Keseru; Adrian Whitty; James A Wells; Sandor Vajda; Dima Kozakov
Journal:  J Med Chem       Date:  2019-07-05       Impact factor: 7.446

Review 8.  Systematic Targeting of Protein-Protein Interactions.

Authors:  Ashley E Modell; Sarah L Blosser; Paramjit S Arora
Journal:  Trends Pharmacol Sci       Date:  2016-06-04       Impact factor: 14.819

9.  Hsp90 chaperones have an energetic hot-spot for binding inhibitors.

Authors:  Reyal S Hoxie; Timothy O Street
Journal:  Protein Sci       Date:  2020-09-08       Impact factor: 6.725

10.  A Computational Investigation of Small-Molecule Engagement of Hot Spots at Protein-Protein Interaction Interfaces.

Authors:  David Xu; Yubing Si; Samy O Meroueh
Journal:  J Chem Inf Model       Date:  2017-08-29       Impact factor: 4.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.